What Finnsusp does

Finnsusp (Oy Finnsusp Ab) is a Finnish family- and employee-owned medical device manufacturer founded in 1978 and headquartered in Lieto, near Turku. Operating under the Piiloset brand domestically and as a private-label/OEM supplier internationally, the company develops and manufactures aseptic, pharmaceutical-grade contact lens care solutions (BioSoak+, BioTwin, OneStep peroxide system) and preservative-free dry eye treatments (BioDrop MD line, PuroSilmille). Core technology rests on proprietary, in-house-developed formulations including a patent-protected clear microemulsion (Puro Suoja) and trehalose-based ocular surface products backed by peer-reviewed research published in Biomolecules. All manufacturing, R&D, and quality control run from a single ISO 13485- and GMP-certified site holding FDA, MDSAP, and Brazilian ANVISA approvals.

The business model is export-led B2B combined with domestic B2C retail. Over 90% of dry eye and contact lens solution production is exported to 35+ countries across Europe, the Middle East, Africa, and the Americas, primarily through private-label contracts with international pharmaceutical companies and wholesalers who resell under their own brands. Domestically, products are sold via optical retail chains, pharmacy chains, and grocery stores under the Piiloset and Puro brands. Revenue streams are one-time product sales rather than subscriptions or licensing royalties, although recurring reorder patterns are implied by multi-year OEM relationships. Current revenue is approximately 11.6–12 million EUR, with a stated objective to at least double by 2030.

In summer 2025, Finnsusp divested its eyeglass lens business — including the OLOlinssit and ProGolf brands and the Linssikauppa.fi e-commerce operation — to IXI Eyewear for approximately $6 million, sharpening strategic focus on contact lens solutions and dry eye products. Concurrent capital investment of approximately 6 million EUR, co-financed by the Ely-keskus and the EU European Regional Development Fund, is funding a new production building (completed mid-2025) and a new bottling line (summer 2026) intended to quintuple production capacity. The company employs approximately 60–70 people, with employee share ownership of nearly 29% established in 2023.

Name

Finnsusp

Legal name

Oy Finnsusp Ab

Website

https://piiloset.fi

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

11–50 employees

Short description

Finnsusp is a Finnish family-owned medical device manufacturer producing aseptic contact lens care solutions and preservative-free dry eye treatments under the Piiloset brand, exporting over 90% of output as private-label products to 35+ countries via international pharmaceutical partners.

Ownership category

akta.pro rank

Product category

Ophthalmic Solutions

NAICS

Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460)

SIC

Ophthalmic Goods (3851)

akta.pro primary industry

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)

Keywords

• Contact lens solutions
• Dry eye treatments
• Ophthalmic manufacturing
• Preservative-free formulations
• Private label eye care

Headquarters

HQ city

Lieto

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contact lens care solutions (export & domestic): Sale of proprietary contact lens care solutions (BioSoak, BioTwin, OneStep) primarily for export, with domestic sales through optical stores and pharmacies.
2. Dry eye treatment products (export & domestic): Sale of preservative-free dry eye products (BioDrop MD, PuroSilmille) under own brands (Piiloset, Puro) domestically and under customer private labels internationally. Majority of export revenue comes from private-label products sold by international pharmaceutical partners.
3. Private-label / contract manufacturing: Large portion of export business is conducted under customers' own brands. International pharmaceutical companies extend their portfolios with Piiloset's dry eye products rather than manufacturing them in-house. Export share of contact lens solutions and dry eye products exceeds 90%.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Finnsusp manufactures and sells contact lens care solutions (BioSoak+, BioTwin, OneStep) and preservative-free dry eye treatment products (BioDrop MD, PuroSilmille, Puro Suoja) under the Piiloset and Puro brands. The company produces over 90% of its output for export to international pharmaceutical partners under private-label agreements across 35+ countries, while also selling its own branded products through Finnish optical stores, pharmacy chains, and grocery retailers.

Product overview

Finnsusp (operates under Piiloset brand) is a Finnish family-owned company specializing in contact lens care solutions and dry eye treatment products. The product portfolio centers on three core areas: (1) Contact lens solutions including BioSoak®+, BioTwin®, and OneStep peroxide system; (2) Dry eye products under Piiloset BioDrop MD® and PuroSilmille® sub-brands, covering eye drops, sprays, and washes; and (3) Accessories including cleaning sprays and foams. The company develops all products internally and manufactures at its own facilities in Lieto, Finland. In 2025, Finnsusp divested its eyeglass lens business (OLOlinssit®, ProGolf®, Linssikauppa.fi) to IXI Eyewear to focus on the growing dry eye and contact lens solution markets.

Differentiator

Problem solved

Functional benefit

Brands

• Piiloset BioDrop MD: Preservative-free dry eye treatment products including drops, plus formula, and spray
• PuroSilmille
• Piiloset BioSoak
• Piiloset BioTwin
• Piiloset OneStep
• OLOlinssit
• ProGolf

Products and services

• PuroSilmille® A comprehensive dry eye treatment product line including 3 eye drops and 1 eye wash solution for treating dry eye conditions. Available at pharmacies and optical stores in Finland.
• Piiloset BioSoak®+ A contact lens disinfecting solution with optimal disinfectant and cleanser concentrations for excellent disinfection without compromising eye comfort.
• Piiloset BioTwin® A multi-function contact lens solution combining cleaning, rinsing, and disinfecting capabilities for lenses.
• Piiloset OneStep A peroxide-based contact lens cleaning system for deep cleaning and disinfection of contact lenses.
• Piiloset BioDrop MD® Preservative-free dry eye drops for lubricating and moisturizing dry eyes. Available in standard formulation.
• Piiloset BioDrop MD® Plus Enhanced version of BioDrop MD with additional formulation designed for more severe dry eye symptoms.
• Piiloset BioDrop MD® Spray Spray formulation of BioDrop MD for convenient on-the-go dry eye relief.
• Puro Suoja A patented microemulsion-based eye drop designed to interrupt the cycle of dry eye symptoms. Unlike typical cloudy emulsions, this product is clear and does not blur vision.
• Piiloset® Vaahtosaippua A specially formulated foam soap for cleaning contact lenses, sold alongside optical and grocery retail channels.
• Piiloset® Puhdistussuihke A cleaning spray suitable for coated eyeglass lenses, touchscreens, displays, binoculars, camera lenses, and safety glasses.

Quantifiable outcome

• Revenue targeted to at least double from ~12 million EUR to ~24+ million EUR by 2030
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered major, supporting and core.

• IXI Eyewear / IXI Optics OymajorStrategic or Co-development Partner · 7 August 2025IXI Eyewear acquired Finnsusp's eyeglass lens manufacturing and development operations in Finland (including OLOlinssit and ProGolf lens brands, Linssikauppa.fi e-commerce, and lens manufacturing staff and sales/customer service organization). The transaction enables Finnsusp to focus exclusively on its core dry eye and contact lens solutions business while IXI gains in-house lens manufacturing capability for its smart autofocus glasses development.
• Ely-keskus (Centre for Economic Development, Transport and the Environment) — FinlandsupportingOthers · 25 June 2025Ely-keskus co-finances Finnsusp's factory expansion and equipment investments through regional development funding, alongside the EU European Regional Development Fund (EAKR). Approximately 6 million EUR total investment underway.
• EU European Regional Development Fund (EAKR / ERDF)supportingOthers · 25 June 2025EU Regional Development Fund co-invests alongside Ely-keskus and Finnsusp's own capital in the approximately 6 million EUR factory expansion project. The investment includes new production building (completed), bottling line (summer 2026), and cleanroom upgrades.
• International pharmaceutical companies (unspecified)coreChannel Partner/ Reseller/ Distributor · 25 June 2025Finnsusp's primary export growth channel. International pharmaceutical companies and wholesalers with existing distribution networks distribute Finnsusp's products under private-label brands across 35+ countries. Partners extend their portfolios to include Finnsusp's preservative-free dry eye products and contact lens solutions. Distribution covers five continents.
• EURA2021 funding programmesupportingOthers · 1 June 2024EURA2021 hankerahoitus (EU funding programme) supported the factory expansion project first phase, which was completed June 2025.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Laboratoires Théa: French specialty ophthalmic company focused on preservative-free formulations (e.g., Thealoz Duo, Thealose) and contact lens care. Closely comparable to Finnsusp's preservative-free dry eye and lens care positioning.
• TRB Chemedica: Privately held ophthalmic specialty company selling preservative-free dry eye and ocular surface products (e.g., Hyabak, Thealoz) in multiple European and international markets. Directly comparable niche player in sterile ophthalmic solutions.
• URSAPHARM: German specialty ophthalmic company behind the Hylo-Comod and Hylo-Fresh preservative-free dry eye range, plus lens care solutions. A direct European competitor to Finnsusp's BioDrop MD and Puro lines.
• Santen Pharmaceutical: Japanese-listed ophthalmic specialty company selling Rx (Ikervis) and OTC dry eye products plus surgical/contact lens care across Europe and Asia. Comparable niche specialist with overlapping preservative-free and sterile ophthalmic capability.
• Croma-Pharma: Austrian ophthalmic and medical aesthetics manufacturer with a preservative-free ophthalmic portfolio. Comparable as a European specialty ophthalmic manufacturer serving international partners via private-label and branded channels.

Broad incumbents

• AbbVie (Allergan Aesthetics / Eye Care): Through the legacy Allergan franchise, AbbVie markets Restasis (cyclosporine) and Refresh Tears in dry eye, plus contact lens-related products. A broad incumbent that overlaps with Finnsusp's preservative-free dry eye niche.
• Bausch + Lomb: Global ophthalmic giant producing Renu and Biotrue contact lens solutions plus a broad dry eye portfolio (Soothe, Artelac). Directly overlaps with Finnsusp's contact lens care and dry eye categories but at vastly larger scale and broader portfolio.
• Johnson & Johnson Vision: Part of Johnson & Johnson, markets contact lens care solutions alongside the Acuvue lens franchise. A direct competitor in the contact lens solutions category Finnsusp targets.
• Alcon: Swiss-listed ophthalmic leader offering Opti-Free and AOSEPT contact lens solutions plus the Systane dry eye range. Competes with Finnsusp across both product pillars but serves a much wider surgical and vision care portfolio.

Emerging players

• OCuSOFT: US-based specialty company focused on dry eye, lid hygiene, and ocular surface products (Retaine, Tears Again). A smaller niche player competing with Finnsusp in preservative-free dry eye offerings for sensitive eyes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/25037215

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Finnsusp